Titel

Merkliste
1 Ergebnisse

Efficacy of third-line anti-EGFR-based treatment versus reg..:

Lisa Salvatore ; Maria Bensi ; Raffaella Vivolo...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1125013/full. , 2023

Link: https://doi.org/10.3389/fonc.2023.1125013

RT Journal
T1 <Title>Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:86c077691eb844e5b6aadfff0bfac739&Exemplar=1&LAN=DE
				
A1 Lisa Salvatore
A1 Maria Bensi
A1 Raffaella Vivolo
A1 Ina Valeria Zurlo
A1 Emanuela Dell'Aquila
A1 Roberta Grande
A1 Annunziato Anghelone
A1 Alessandra Emiliani
A1 Fabrizio Citarella
A1 Maria Alessandra Calegari
A1 Marta Ribelli
A1 Michele Basso
A1 Carmelo Pozzo
A1 Giampaolo Tortora
PB Frontiers Media S.A.
YR 2023
K1 colorectal cancer
K1 primary tumor site
K1 third-line therapy
K1 RAS/BRAF wild-type
K1 anti-egfr ab
K1 Regorafenib
K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens
K1 RC254-282
JF https://www.frontiersin.org/articles/10.3389/fonc.2023.1125013/full
LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1125013
DO https://doi.org/10.3389/fonc.2023.1125013
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)